About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,539 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,539 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6281-6300 of 7,539 trials

RecruitingHead-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and MetastasisTo prospectively evaluate the radiodrug biodistribution of a novel PET imaging agent \[18F\]AlF-PSMA-N5 in different organs of prostate cancer patients and its diagnostic efficacy…NCT06756334·Hefei, Anhui TerminatedPhase II Trial of Transdermal Estradiol for Hormone Refractory Prostate CancerMultiple trials have shown the efficacy of estrogen therapy in metastatic prostate cancer, and most recently trials have supported the use of transdermal estrogens (patch) in the…NCT00176644·Freehold, New Jersey and 5 others CompletedTaste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate CancerThis study is a sensory analysis of several different formulations of a novel tomato-soy-arugula seed beverage in men with prostate cancer.NCT02927899·Columbus, Ohio

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedBi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerThis pilot study is designed to determine the feasibility and safety of administering docetaxel at various dosing levels on a bi-weekly schedule in older men with hormone…NCT00215709·Baltimore, Maryland

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others

CompletedTo Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer PatientsProstate cancer is the second most common cancer in male cancer globally and ranked third in Hong Kong.NCT04687709·Shatin

WithdrawnEffects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate CancerProstate cancer is the cause of the greatest number of years lived with disability due to cancer.NCT03308734·Gloucester

TerminatedHigh Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical ProstatectomyThis prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-PSMA PET-MRI) will detect prostate cancers…NCT04461509·Los Angeles, California

CompletedIncidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the USThis study is conducted to estimate population-based incidence rates of second primary malignancies among patients with CRPC similar to those treated with Xofigo.NCT02788409·Waltham, Massachusetts

UnknownAnalysis of a New Biomarker for Prostate Cancer DiagnosisThe aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.NCT01819740·Sabadell, Barcelona

RecruitingPhase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate CancerThis is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK（pharmacokinetics） and PD（pharmacodynamics） of HSK46575 when given…NCT07007910·Chengdu, Sichuan

RecruitingNeoadjuvant PSMA-RLT in Oligometastatic PCaProspective single-center phase II study to evaluate the PSA, imaging and pathological response, as well as oncological outcomes of systemic radioligand therapy…NCT06259123·Vienna

Active not recruitingTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringThis phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active…NCT04597359·Fairbanks, Alaska and 352 others

UnknownProstate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells.NCT00567580·Birmingham, Alabama and 459 others

RecruitingTransperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) RegistryRationale: Transperineal laser ablation (TPLA) treatment for prostate cancer (PCa) is a minimal invasive focal therapy technique studied worldwide to determine its efficacy.NCT05163197·Amsterdam

RecruitingDose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two FractionsThe goal of this clinical trial is to find out whether lowering the radiation dose to parts of the prostate without visible tumor on MRI can reduce side effects while still…NCT07391982·Amsterdam

UnknownDigital Rectal Exam Proficiency ToolA digital rectal exam proficiency tool, titled the 'DiRECT' was developed based on the consensus of 10 experts.NCT02278679·Charlottesville, Virginia

RecruitingLu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative RadiotherapyThe aim of this study is to assess the progression free survival (PFS) of SABR alone and SABR + 177Lu-prostate-specific membrane antigen (PSMA) in patients with oligometastatic…NCT05560659·St Leonards, New South Wales and 2 others

CompletedPhase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory TumoursLiposomal formulations are frequently used today in the treatment of cancer.NCT01861496·Copenhagen and 3 others

UnknownTrial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate CancerProspective non-randomized phase 2 trial to study the efficacy of additional elective para-aortic RT (PART) in pN1 patients compared to those who were historically treated with…NCT03079323·Leuven

PreviousPage 315 of 377Next